Next spring, 20 of the most outstanding high-school seniors in Arizona will be selected as the 35th class of Flinn Scholars.
Author Archive: AZBio
It’s Time to Apply for the Fall 2019 Arizona Innovation Challenge
Arizona Commerce Authority opens application window for the Fall 2019 Arizona Innovation Challenge.
Applications will be accepted beginning on Thursday, September 5 through Friday, September 27 at 5 p.m MST
Learn more and apply at azcommerce.com/programs/arizona-innovation-challenge/apply/
Continue reading
UA College of Medicine – Tucson Professor Honored by National Academy of Inventors
TUCSON, Ariz. – Professor of Medicine and Phase 1 Program Director at the University of Arizona Cancer Center and the College of Medicine – Tucson Daruka Mahadevan, MD/PhD, has been recognized as a Senior Member of the National Academy of Inventors.Continue reading
UA Awarded $1.4M Grant for Program that Supports Sleep Apnea Patients
Peers will help newly diagnosed sleep-apnea patients get the most out of CPAP treatment, which saves lives but is difficult for many patients to follow.Continue reading
SBA Announces a Major Change to SBIR/STTR Data Rights Protection
On April 3, 2019, the Small Business Association (SBA) released a revised Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) program policy directive, which went into effect May 2, 2019 (the “New Policy”).1 This New Policy made important and drastic changes to Data Rights protections afforded to SBIR/STTR awarded small business companies. Government contractors should understand these major changes and consider the impact on company operations related to commercialization of intellectual property developed with government funding.Continue reading
PADT Adds the Faster, Larger and More Advanced Stratasys F900 Fused Deposition Modeling Additive Manufacturing System at its Tempe Headquarters
The F900 is the Most Capable System on the Market for Companies Who Need Large, 3D-Printed Production Parts in Small or Large Volume.Continue reading
Roche launches VENTANA PD-L1 (SP142) Assay in CE markets as first companion diagnostic to identify triple-negative breast cancer patients eligible for treatment with Tecentriq
This launch represents an important step in Roche’s personalised healthcare strategy to fit treatments to patients who can benefit most from a specific medicine.
Each year 300,000 patients around the world are diagnosed with triple-negative breast cancer, an aggressive disease with limited treatment options1,2
VENTANA PD-L1 (SP142) Assay helps identify triple-negative breast cancer patients most likely to benefit from treatment with Tecentriq plus chemotherapy
OncoMyx Therapeutics, Inc. to be honored with an AZBio Fast Lane Award
CHANDLER, Ariz — (BUSINESS WIRE) — The Arizona Bioindustry Association (AZBio) today announced that OncoMyx Therapeutics, Inc. has been named an AZBio Fast Lane Company and will be honored on October 2, 2019 at the AZBio Awards.Continue reading
GT Medical Technologies, Inc. to be honored with an AZBio Fast Lane Award
CHANDLER, Ariz — (BUSINESS WIRE) — The Arizona Bioindustry Association (AZBio) today announced that GT Medical Technologies, Inc. (GT MedTech) has been named an AZBio Fast Lane Company and will be honored on October 2, 2019 at the AZBio Awards.Continue reading